Contact this trialFirst, we need to learn more about you.
IDH1 Inhibitor
AG-120 for Chondrosarcoma
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing AG-120, to see if it is safe and effective in people with chondrosarcoma that has returned or spread, and has an IDH1 mutation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service